Publisher’s Intro by David Wallace As a certified, red-blooded JAK2 positive Polycythemia Vera (PV) patient, I have always been fascinated by the events leading up to a PV diagnosis. By sharing our stories, perhaps we offer “a dose of comfort” to the new or recently diagnosed. When they read of struggles that other patient’s experience, […]
Leukemia & Lymphoma Society Launches New Program to Halt Progression of Myeloid Blood Cancers
The LLS and Janssen Research & Development, LLC have committed $1.7 million for the initiative White Plains, NY (October 28, 2014) – The Leukemia & Lymphoma Society has initiated a program to fund research projects seeking to better understand and, ultimately, stop progression of certain types of blood cancers from early-stage malignancies to much more […]
MPN Clinical Trial updates from Geron and Promedior
Geron announces removal of Full Clinical Hold on Imetelstat The full clinical hold on Geron’s sole pipeline candidate, investigation new drug (IND), Imetelstat, has been lifted by the FDA. The company does not intend to conduct further studies or develop imetelstat for the treatment of essential thrombocythemia (ET) or polycythemia vera (PV). The development plan […]
PV Reporter introduces new Mobile App
MPN Information on Your Phone PV Reporter has introduced a new mobile app that you can download to your phone (iOS). The app provides instant access to multiple pages on our website (MPN Search, Specialists, Blog, Resources), Facebook page, Twitter page, PV Tracker Tool, email contact information and the ability to share the app via […]
Tips on How to treat your Chronically Ill Friend
Publisher’s Note I discovered the article “10 Tips of How to be a Friend to a Chronically Ill Sufferer” on Facebook and found it to be relevant for many MPN patients. I asked Mary McGregor, the author, if I could feature it on PV Reporter and she agreed. I like her self-described “rant” style, it […]
- « Previous Page
- 1
- …
- 30
- 31
- 32
- 33
- 34
- …
- 43
- Next Page »
